| (a) The Institute shall accept Grant Applications for
Cancer Research and Cancer Prevention programs to be funded by the
Cancer Prevention and Research Fund or the proceeds of general obligation
bonds issued on behalf of the Institute in response to standard format
Requests for Applications issued by the Institute.
(b) Each Request for Applications shall be publicly
available through the Institute's Internet website. The Institute
reserves the right to modify the format and content requirements for
the Requests for Applications from time to time. Any modifications
will be available through the Institute's Internet website. The Request
for Applications shall:
(1) Include guidelines for the proposed projects and
may be accompanied by instructions provided by the Institute.
(2) State the criteria to be used during the Grant
Review Process to evaluate the merit of the Grant Application, including
guidance regarding the range of possible scores.
(A) The specific criteria and scoring guidance shall
be developed by the Chief Program Officer in consultation with the
Review Council.
(B) When the Institute will use a preliminary evaluation
process as described in §703.6 of this chapter (relating to Grant
Review Process) for the Grant Applications submitted pursuant to a
particular Grant Mechanism, the Request for Applications shall state
the criteria and Grant Application components to be included in the
preliminary evaluation.
(3) Specify limits, if any, on the number of Grant
Applications that may be submitted by an entity for a particular Grant
Mechanism to ensure timely and high-quality review when a large number
of Grant Applications are anticipated.
(4) Specify the minimum level of effort, if any, for
the Principal Investigator, co-Principal Investigator, and other specified
key personnel of an entity approved for a Grant Award.
(c) Requests for Applications for Cancer Research and
Cancer Prevention projects issued by the Institute may address, but
are not limited to, the following areas:
(1) Basic research;
(2) Translational research, including proof of concept,
preclinical, and Product Development activities;
(3) Clinical research;
(4) Population based research;
(5) Training;
(6) Recruitment to the state of researchers and clinicians
with innovative Cancer Research approaches;
(7) Infrastructure, including centers, core facilities,
and shared instrumentation;
(8) Implementation of the Texas Cancer Plan; and
(9) Evidence based Cancer Prevention education, outreach,
and training, and clinical programs and services.
(d) An otherwise qualified applicant is eligible solely
for the Grant Mechanism specified by the Request for Applications
under which the Grant Application was submitted.
(e) The Institute may limit the number of times a Grant
Application not recommended for a Grant Award during a previous Grant
Review Cycle may be resubmitted in a subsequent Grant Review Cycle.
The Request for Applications will state the resubmission guidelines,
including specific instructions for resubmissions.
(f) Failure to comply with the material and substantive
requirements set forth in the Request for Applications may serve as
grounds for disqualification from further consideration of the Grant
Application by the Institute. A Grant Application determined by the
Institute to be incomplete or otherwise noncompliant with the terms
or instructions set forth by the Request for Applications shall not
be eligible for consideration of a Grant Award.
(g) Only those Grant Applications submitted via the
designated electronic portal designated by the Institute by the deadline,
if any, stated in the Request for Applications shall be eligible for
consideration of a Grant Award.
(1) Nothing herein shall prohibit the Institute from
extending the submission deadline for one or more Grant Applications
upon a showing of good cause, as determined by the Chief Program Officer.
(2) A request to extend the Grant Application submission
deadline must be in writing and sent to the CPRIT Helpdesk via electronic
mail, within 24 hours of the submission deadline.
(3) The Institute shall document any deadline extension
granted, including the good cause for extending the deadline and will
cause the documentation to be maintained as part of the Grant Review
Process records.
(h) The Grant Applicant shall certify that it has not
made and will not make a donation to the Institute or any foundation
created to benefit the Institute.
(1) Grant Applicants that make a donation to the Institute
or any foundation created to benefit the Institute on or after June
14, 2013, are ineligible to be considered for a Grant Award.
(2) For purposes of the required certification, the
Grant Applicant includes the following individuals or the spouse or
dependent child(ren) of the following individuals:
(A) the Principal Investigator, Program Director, or
Company Representative;
(B) a Senior Member or Key Personnel listed on the
Grant Application; and
(C) an officer or director of the Grant Applicant.
(3) Notwithstanding the foregoing, one or more donations
exceeding $500 by an employee of a Grant Applicant not described by
paragraph (2) of this subsection shall be considered to be made on
behalf of the Grant Applicant for purposes of the certification.
(4) The certification shall be made at the time the
Grant Application is submitted.
(5) The Chief Compliance Officer shall compare the
list of Grant Applicants to a current list of donors to the Institute
and any foundation created to benefit the Institute.
(6) To the extent that the Chief Compliance Officer
has reason to believe that a Grant Applicant has made a donation to
the Institute or any foundation created to benefit the Institute,
the Chief Compliance Officer shall seek information from the Grant
Applicant to resolve any issue. The Grant Application may continue
in the Grant Review Process during the time the additional information
is sought and under review by the Institute.
(7) If the Chief Compliance Officer determines that
the Grant Applicant has made a donation to the Institute or any foundation
created to benefit the Institute, then the Institute shall take appropriate
action. Appropriate action may entail:
(A) Withdrawal of the Grant Application from further
consideration; or
(B) Return of the donation, if the return of the donation
is possible without impairing Institute operations.
(8) If the donation is returned to the Applicant, then
the Grant Application is eligible to be considered for a Grant Award.
(i) Grant Applicants shall identify by name all sources
of funding contributing to the project proposed for a Grant Award.
A Grant Applicant for a Product Development Research Grant Award must
provide a capitalization table that includes those individuals or
entities that have an investment, stock or rights in the company.
The Institute shall make the information provided by the Grant Applicant
available to Scientific Research and Prevention Programs Committee
members, Institute employees, independent contractors participating
in the Grant Review Process, Program Integration Committee Members
and Oversight Committee Members for purposes of identifying potential
Conflicts of Interest prior to reviewing or taking action on the Grant
Application. The information shall be maintained in the Institute's
Grant Review Process records.
(j) A Grant Applicant shall indicate if the Grant Applicant
is currently ineligible to receive Federal or State grant funds due
to debarment or suspension or if the Grant Applicant has had a grant
terminated for cause within five years prior to the submission date
of the Grant Application. For purposes of the provision, the term
Grant Applicant includes the personnel, including collaborators or
contractors, who will be working on the Grant Award. A Grant Applicant
is not eligible to receive a Grant Award if the Grant Applicant is
debarred, suspended, ineligible or otherwise excluded from participation
in a federal or state grant award.
(k) The Institute may require each Grant Applicant
for a Cancer Research Grant Award for Product Development to submit
an application fee.
(1) The Chief Executive Officer shall adopt a policy
regarding the application fee amount.
(2) The Institute shall use the application fee amounts
to defray the Institute's costs associated with the Product Development
review processes, including due diligence and intellectual property
reviews, as specified in the Request for Application.
Cont'd... |
